Ryu Watanabe

4.2k citations

125 papers · 2.7k indexed · 1 hit paper · h-index 28

Impact in

Rheumatology top 1%
- Systemic Lupus Erythematosus Research
- Otitis Media and Relapsing Polychondritis
- Rheumatoid Arthritis Research and Therapies
Immunology top 2%
- Atherosclerosis and Cardiovascular Diseases
- Immune cells in cancer
- Immune Cell Function and Interaction

Papers in ⓘ

Rheumatology 63
- Systemic Lupus Erythematosus Research 30
- Rheumatoid Arthritis Research and Therapies 23
- Urticaria and Related Conditions 9
Immunology and Allergy 15
- Cell Adhesion Molecules Research 15

Co-authors: Cornelia M. Weyand (19 shared papers)Jörg J. Goronzy (19 shared papers)Gerald J. Berry (16 shared papers)Hui Zhang (14 shared papers)Motomu Hashimoto (54 shared papers)Lü Tian (4 shared papers)Tsuyoshi Shirai (15 shared papers)Barbara B. Wallis (5 shared papers)
Journals: Modern Rheumatology (16 papers)Arthritis Research & Therapy (9 papers)Frontiers in Immunology (7 papers)Annals of the Rheumatic Diseases (7 papers)Lara D. Veeken (6 papers)
Partner nations: Japan United States China

In The Last Decade

Ryu Watanabe

116 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease 2016 · 428 citations

Peers

Countries citing papers authored by Ryu Watanabe

Since Specialization

Citations

This map shows the geographic impact of Ryu Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryu Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryu Watanabe more than expected).

Fields of papers citing papers by Ryu Watanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryu Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryu Watanabe. The network helps show where Ryu Watanabe may publish in the future.

Co-authors

The 25 scholars most cited alongside Ryu Watanabe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryu Watanabe Line = papers co-authored together Ryu Watanabe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease The Journal of Experimental Medicine ·Tsuyoshi Shirai, Rafal R. Nazarewicz, Barbara B. Wallis, Rolando E. Yanes, Ryu Watanabe, Marc Hilhorst, Lü Tian, David G. Harrison, John C. Giacomini, Themistocles L. Assimes, Jörg J. Goronzy, Cornelia M. Weyand Hit paper breakdown →	2016	428
2	Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis Proceedings of the National Academy of Sciences ·Hui Zhang, Ryu Watanabe, Gerald J. Berry, Augusto Vaglio, Yaping Joyce Liao, Kenneth J. Warrington, Jörg J. Goronzy, Cornelia M. Weyand	2017	191
3	Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis Circulation ·Hui Zhang, Ryu Watanabe, Gerald J. Berry, Lü Tian, Jörg J. Goronzy, Cornelia M. Weyand	2017	171
4	MMP (Matrix Metalloprotease)-9–Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis Circulation Research ·Ryu Watanabe, Toshihisa Maeda, Hui Zhang, Gerald J. Berry, Markus Zeisbrich, Robert Brockett, Andrew E. Greenstein, Lü Tian, Jörg J. Goronzy, Cornelia M. Weyand	2018	121
5	The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway Science Translational Medicine ·Zhenke Wen, Yi Shen, Gerald J. Berry, Farhad Shahram, Yinyin Li, Ryu Watanabe, Yaping Joyce Liao, Jörg J. Goronzy, Cornelia M. Weyand	2017	103
6	Immune checkpoint dysfunction in large and medium vessel vasculitis American Journal of Physiology-Heart and Circulatory Physiology ·Ryu Watanabe, Hui Zhang, Gerald J. Berry, Jörg J. Goronzy, Cornelia M. Weyand	2017	91
7	Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation Annals of the Rheumatic Diseases ·Markus Zeisbrich, Rolando E. Yanes, Hui Zhang, Ryu Watanabe, Yinyin Li, Lukas Brosig, Jison Hong, Barbara B. Wallis, John C. Giacomini, Themistocles L. Assimes, Jörg J. Goronzy, Cornelia M. Weyand	2018	84
8	Glucose metabolism controls disease-specific signatures of macrophage effector functions JCI Insight ·Ryu Watanabe, Marc Hilhorst, Hui Zhang, Markus Zeisbrich, Gerald J. Berry, Barbara B. Wallis, David G. Harrison, John C. Giacomini, Jörg J. Goronzy, Cornelia M. Weyand	2018	76
9	Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity Journal of Clinical Investigation ·Ryu Watanabe, Tsuyoshi Shirai, Hong Namkoong, Hui Zhang, Gerald J. Berry, Barbara B. Wallis, Benedikt Schaefgen, David G. Harrison, Jennifer A. Tremmel, John C. Giacomini, Jörg J. Goronzy, Cornelia M. Weyand	2017	72
10	Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis—Similarities and Differences Current Rheumatology Reports ·Ryu Watanabe, Gerald J. Berry, David Liang, Jörg J. Goronzy, Cornelia M. Weyand	2020	69
11	Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus Modern Rheumatology ·Tomonori Ishii, Yoshiya Tanaka, Atsushi Kawakami, Kazuyoshi Saito, Kunihiro Ichinose, Hiroshi Fujii, Yuko Shirota, Tsuyoshi Shirai, Yoko Fujita, Ryu Watanabe, Shih-Wei Chiu, Takuhiro Yamaguchi, Hideo Harigae	2018	54
12	Role of Lysine‐Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia‐Inducible Factor 1α and E2F1 Arthritis & Rheumatology ·Kohei Doi, Koichi Murata, Shuji Ito, Akari Suzuki, Chikashi Terao, Shinichiro Ishie, Akio Umemoto, Yoshiki Murotani, Kohei Nishitani, Hiroyuki Yoshitomi, Takayuki Fujii, Ryu Watanabe, Motomu Hashimoto, Kosaku Murakami, Masao Tanaka, Hiromu Ito, Kyung‐Hyun Park‐Min, Lionel B. Ivashkiv, Akio Morinobu, Shuichi Matsuda	2022	44
13	Cellular Signaling Pathways in Medium and Large Vessel Vasculitis Frontiers in Immunology ·Ryu Watanabe, Gerald J. Berry, David Liang, Jörg J. Goronzy, Cornelia M. Weyand	2020	44
14	Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort Immunological Medicine ·Ryu Watanabe, Motomu Hashimoto, Koichi Murata, Kosaku Murakami, Masao Tanaka, Koichiro Ohmura, Hiromu Ito, Shuichi Matsuda	2021	43
15	CD28 Signaling Controls Metabolic Fitness of Pathogenic T Cells in Medium and Large Vessel Vasculitis Journal of the American College of Cardiology ·Hui Zhang, Ryu Watanabe, Gerald J. Berry, Steven G. Nadler, Jörg J. Goronzy, Cornelia M. Weyand	2019	40
16	Difficult-to-treat rheumatoid arthritis: Current concept and unsolved problems Frontiers in Medicine ·Ryu Watanabe, Tadashi Okano, Takaho Gon, N. Yoshida, Kazuo Fukumoto, Shinsuke Yamada, Motomu Hashimoto	2022	38
17	Vasculitis associated with VEXAS syndrome: A literature review Frontiers in Medicine ·Ryu Watanabe, Manami Kiji, Motomu Hashimoto	2022	35
18	Giant Cell Arteritis: From Pathogenesis to Therapeutic Management PubMed ·Ryu Watanabe, Jörg J. Goronzy, Gerald J. Berry, Yaping Joyce Liao, Cornelia M. Weyand	2016	35
19	Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors Modern Rheumatology ·Mariko Ishizuka, Ryu Watanabe, Tomonori Ishii, Tomoaki Machiyama, Kanae Akita, Yoko Fujita, Yuko Shirota, Hiroshi Fujii, Hideo Harigae	2015	34
20	Cytokines, growth factors and proteases in medium and large vessel vasculitis Clinical Immunology ·Cornelia M. Weyand, Ryu Watanabe, Hui Zhang, Mitsuhiro Akiyama, Gerald J. Berry, Jörg J. Goronzy	2019	34

About Ryu Watanabe

Ryu Watanabe is a scholar working on Rheumatology, Immunology and Allergy, Immunology, Microbiology and Pulmonary and Respiratory Medicine, having authored 125 papers that have together received 2.7k indexed citations. Recurring topics across this work include Vasculitis and related conditions (36 papers), Systemic Lupus Erythematosus Research (30 papers), Atherosclerosis and Cardiovascular Diseases (25 papers), Rheumatoid Arthritis Research and Therapies (23 papers), Cell Adhesion Molecules Research (15 papers), Urticaria and Related Conditions (9 papers), Autoimmune and Inflammatory Disorders Research (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Rheumatology (967 citations), Immunology (1.1k citations), Immunology and Allergy (196 citations), Pulmonary and Respiratory Medicine (987 citations) and Genetics (289 citations). Ryu Watanabe has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Cornelia M. Weyand, Jörg J. Goronzy, Gerald J. Berry, Hui Zhang, Motomu Hashimoto, Lü Tian, Tsuyoshi Shirai, Barbara B. Wallis, John C. Giacomini and David G. Harrison. Their work appears in journals such as Modern Rheumatology, Arthritis Research & Therapy, Frontiers in Immunology, Annals of the Rheumatic Diseases and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact